Host Protein General Information
Protein Name |
Mitogen-activated protein kinase 1
|
Gene Name |
MAPK1
|
||||||
---|---|---|---|---|---|---|---|---|---|
Host Species |
Homo sapiens
|
Uniprot Entry Name |
MK01_HUMAN
|
||||||
Protein Families |
Protein kinase superfamily
|
||||||||
EC Number |
2.7.11.24
|
||||||||
Subcellular Location |
Cytoplasm; cytoskeleton; spindle
|
||||||||
External Link | |||||||||
NCBI Gene ID | |||||||||
Uniprot ID | |||||||||
Ensembl ID | |||||||||
HGNC ID | |||||||||
Related KEGG Pathway | |||||||||
Chemokine signaling pathway | hsa04062 |
Pathway Map ![]() |
|||||||
Platelet activation | hsa04611 |
Pathway Map ![]() |
|||||||
Neutrophil extracellular trap formation | hsa04613 |
Pathway Map ![]() |
|||||||
Toll-like receptor signaling pathway | hsa04620 |
Pathway Map ![]() |
|||||||
NOD-like receptor signaling pathway | hsa04621 |
Pathway Map ![]() |
|||||||
C-type lectin receptor signaling pathway | hsa04625 |
Pathway Map ![]() |
|||||||
Natural killer cell mediated cytotoxicity | hsa04650 |
Pathway Map ![]() |
|||||||
IL-17 signaling pathway | hsa04657 |
Pathway Map ![]() |
|||||||
Th1 and Th2 cell differentiation | hsa04658 |
Pathway Map ![]() |
|||||||
Th17 cell differentiation | hsa04659 |
Pathway Map ![]() |
|||||||
T cell receptor signaling pathway | hsa04660 |
Pathway Map ![]() |
|||||||
B cell receptor signaling pathway | hsa04662 |
Pathway Map ![]() |
|||||||
Fc epsilon RI signaling pathway | hsa04664 |
Pathway Map ![]() |
|||||||
Fc gamma R-mediated phagocytosis | hsa04666 |
Pathway Map ![]() |
|||||||
Pathogenic Escherichia coli infection | hsa05130 |
Pathway Map ![]() |
|||||||
Shigellosis | hsa05131 |
Pathway Map ![]() |
|||||||
Salmonella infection | hsa05132 |
Pathway Map ![]() |
|||||||
Pertussis | hsa05133 |
Pathway Map ![]() |
|||||||
Yersinia infection | hsa05135 |
Pathway Map ![]() |
|||||||
Tuberculosis | hsa05152 |
Pathway Map ![]() |
|||||||
Leishmaniasis | hsa05140 |
Pathway Map ![]() |
|||||||
Chagas disease | hsa05142 |
Pathway Map ![]() |
|||||||
Toxoplasmosis | hsa05145 |
Pathway Map ![]() |
|||||||
Hepatitis C | hsa05160 |
Pathway Map ![]() |
|||||||
Hepatitis B | hsa05161 |
Pathway Map ![]() |
|||||||
Human cytomegalovirus infection | hsa05163 |
Pathway Map ![]() |
|||||||
Influenza A | hsa05164 |
Pathway Map ![]() |
|||||||
Human papillomavirus infection | hsa05165 |
Pathway Map ![]() |
|||||||
Human T-cell leukemia virus 1 infection | hsa05166 |
Pathway Map ![]() |
|||||||
Kaposi sarcoma-associated herpesvirus infection | hsa05167 |
Pathway Map ![]() |
|||||||
Human immunodeficiency virus 1 infection | hsa05170 |
Pathway Map ![]() |
|||||||
Coronavirus disease - COVID-19 | hsa05171 |
Pathway Map ![]() |
|||||||
EGFR tyrosine kinase inhibitor resistance | hsa01521 |
Pathway Map ![]() |
|||||||
Endocrine resistance | hsa01522 |
Pathway Map ![]() |
|||||||
Platinum drug resistance | hsa01524 |
Pathway Map ![]() |
|||||||
Pathways in cancer | hsa05200 |
Pathway Map ![]() |
|||||||
Viral carcinogenesis | hsa05203 |
Pathway Map ![]() |
|||||||
Proteoglycans in cancer | hsa05205 |
Pathway Map ![]() |
|||||||
MicroRNAs in cancer | hsa05206 |
Pathway Map ![]() |
|||||||
Chemical carcinogenesis - receptor activation | hsa05207 |
Pathway Map ![]() |
|||||||
Chemical carcinogenesis - reactive oxygen species | hsa05208 |
Pathway Map ![]() |
|||||||
Central carbon metabolism in cancer | hsa05230 |
Pathway Map ![]() |
|||||||
Choline metabolism in cancer | hsa05231 |
Pathway Map ![]() |
|||||||
PD-L1 expression and PD-1 checkpoint pathway in cancer | hsa05235 |
Pathway Map ![]() |
|||||||
Colorectal cancer | hsa05210 |
Pathway Map ![]() |
|||||||
Renal cell carcinoma | hsa05211 |
Pathway Map ![]() |
|||||||
Pancreatic cancer | hsa05212 |
Pathway Map ![]() |
|||||||
Endometrial cancer | hsa05213 |
Pathway Map ![]() |
|||||||
Glioma | hsa05214 |
Pathway Map ![]() |
|||||||
Prostate cancer | hsa05215 |
Pathway Map ![]() |
|||||||
Thyroid cancer | hsa05216 |
Pathway Map ![]() |
|||||||
Melanoma | hsa05218 |
Pathway Map ![]() |
|||||||
Bladder cancer | hsa05219 |
Pathway Map ![]() |
|||||||
Chronic myeloid leukemia | hsa05220 |
Pathway Map ![]() |
|||||||
Acute myeloid leukemia | hsa05221 |
Pathway Map ![]() |
|||||||
Non-small cell lung cancer | hsa05223 |
Pathway Map ![]() |
|||||||
Breast cancer | hsa05224 |
Pathway Map ![]() |
|||||||
Hepatocellular carcinoma | hsa05225 |
Pathway Map ![]() |
|||||||
Gastric cancer | hsa05226 |
Pathway Map ![]() |
|||||||
Lipid and atherosclerosis | hsa05417 |
Pathway Map ![]() |
|||||||
Oocyte meiosis | hsa04114 |
Pathway Map ![]() |
|||||||
Apoptosis | hsa04210 |
Pathway Map ![]() |
|||||||
Cellular senescence | hsa04218 |
Pathway Map ![]() |
|||||||
Regulation of actin cytoskeleton | hsa04810 |
Pathway Map ![]() |
|||||||
Focal adhesion | hsa04510 |
Pathway Map ![]() |
|||||||
Adherens junction | hsa04520 |
Pathway Map ![]() |
|||||||
Gap junction | hsa04540 |
Pathway Map ![]() |
|||||||
Signaling pathways regulating pluripotency of stem cells | hsa04550 |
Pathway Map ![]() |
|||||||
Adrenergic signaling in cardiomyocytes | hsa04261 |
Pathway Map ![]() |
|||||||
Vascular smooth muscle contraction | hsa04270 |
Pathway Map ![]() |
|||||||
Axon guidance | hsa04360 |
Pathway Map ![]() |
|||||||
Osteoclast differentiation | hsa04380 |
Pathway Map ![]() |
|||||||
Type II diabetes mellitus | hsa04930 |
Pathway Map ![]() |
|||||||
AGE-RAGE signaling pathway in diabetic complications | hsa04933 |
Pathway Map ![]() |
|||||||
Cushing syndrome | hsa04934 |
Pathway Map ![]() |
|||||||
Insulin signaling pathway | hsa04910 |
Pathway Map ![]() |
|||||||
GnRH signaling pathway | hsa04912 |
Pathway Map ![]() |
|||||||
Progesterone-mediated oocyte maturation | hsa04914 |
Pathway Map ![]() |
|||||||
Estrogen signaling pathway | hsa04915 |
Pathway Map ![]() |
|||||||
Melanogenesis | hsa04916 |
Pathway Map ![]() |
|||||||
Prolactin signaling pathway | hsa04917 |
Pathway Map ![]() |
|||||||
Thyroid hormone signaling pathway | hsa04919 |
Pathway Map ![]() |
|||||||
Oxytocin signaling pathway | hsa04921 |
Pathway Map ![]() |
|||||||
Relaxin signaling pathway | hsa04926 |
Pathway Map ![]() |
|||||||
Parathyroid hormone synthesis, secretion and action | hsa04928 |
Pathway Map ![]() |
|||||||
GnRH secretion | hsa04929 |
Pathway Map ![]() |
|||||||
Growth hormone synthesis, secretion and action | hsa04935 |
Pathway Map ![]() |
|||||||
Circadian entrainment | hsa04713 |
Pathway Map ![]() |
|||||||
Aldosterone-regulated sodium reabsorption | hsa04960 |
Pathway Map ![]() |
|||||||
Long-term potentiation | hsa04720 |
Pathway Map ![]() |
|||||||
Neurotrophin signaling pathway | hsa04722 |
Pathway Map ![]() |
|||||||
Retrograde endocannabinoid signaling | hsa04723 |
Pathway Map ![]() |
|||||||
Glutamatergic synapse | hsa04724 |
Pathway Map ![]() |
|||||||
Cholinergic synapse | hsa04725 |
Pathway Map ![]() |
|||||||
Serotonergic synapse | hsa04726 |
Pathway Map ![]() |
|||||||
Long-term depression | hsa04730 |
Pathway Map ![]() |
|||||||
Alzheimer disease | hsa05010 |
Pathway Map ![]() |
|||||||
Prion disease | hsa05020 |
Pathway Map ![]() |
|||||||
Pathways of neurodegeneration - multiple diseases | hsa05022 |
Pathway Map ![]() |
|||||||
MAPK signaling pathway | hsa04010 |
Pathway Map ![]() |
|||||||
ErbB signaling pathway | hsa04012 |
Pathway Map ![]() |
|||||||
Ras signaling pathway | hsa04014 |
Pathway Map ![]() |
|||||||
Rap1 signaling pathway | hsa04015 |
Pathway Map ![]() |
|||||||
cGMP-PKG signaling pathway | hsa04022 |
Pathway Map ![]() |
|||||||
cAMP signaling pathway | hsa04024 |
Pathway Map ![]() |
|||||||
HIF-1 signaling pathway | hsa04066 |
Pathway Map ![]() |
|||||||
FoxO signaling pathway | hsa04068 |
Pathway Map ![]() |
|||||||
Sphingolipid signaling pathway | hsa04071 |
Pathway Map ![]() |
|||||||
Phospholipase D signaling pathway | hsa04072 |
Pathway Map ![]() |
|||||||
mTOR signaling pathway | hsa04150 |
Pathway Map ![]() |
|||||||
PI3K-Akt signaling pathway | hsa04151 |
Pathway Map ![]() |
|||||||
TGF-beta signaling pathway | hsa04350 |
Pathway Map ![]() |
|||||||
VEGF signaling pathway | hsa04370 |
Pathway Map ![]() |
|||||||
Apelin signaling pathway | hsa04371 |
Pathway Map ![]() |
|||||||
TNF signaling pathway | hsa04668 |
Pathway Map ![]() |
|||||||
Alcoholism | hsa05034 |
Pathway Map ![]() |
|||||||
Autophagy - animal | hsa04140 |
Pathway Map ![]() |
|||||||
3D Structure |
|
Full List of Virus RNA Interacting with This Protien
Virus Name | Binding Region | RNA Info | Detection Method | Infection Cell | Cell ID | Cell Originated Tissue | Infection Time | Interaction Score 1 | Interaction Score 2 |
---|---|---|---|---|---|---|---|---|---|
Encephalomyocarditis virus | 5'UTR - 3'UTR | RNA Info | Comprehensive identification of RNA-binding proteins by mass spectrometry (ChIRP-MS) | HuH-7.5 Cells (Human hepatocellular carcinoma cell) | . | Liver | . | Z-score = -4.727790429 | FZR = 0.0011485 |
Influenza A virus | 5'UTR - 3'UTR | RNA Info | Comprehensive identification of RNA-binding proteins by mass spectrometry (ChIRP-MS) | HuH-7.5 Cells (Human hepatocellular carcinoma cell) | . | Liver | . | Z-score = 1.787325221 | FZR = 1 |
Severe acute respiratory syndrome coronavirus 2 (strain hCoV-19/USA/WA1/2020) | Not Specified Virus Region | RNA Info | ChIRP-MS | Huh7.5 cells (Hepatocyte derived cellular carcinoma cell) | . | Liver | 48 h | FDR <= 0.05 | . |
Potential Drug(s) that Targets This Protein
Protein Sequence Information
MAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS
Click to Show/Hide
|